J 2007

T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency

LITZMAN, Jiří; Marcela VLKOVÁ; Zdenka PIKULOVÁ; Dagmar ŠTIKAROVSKÁ; Jindřich LOKAJ et al.

Základní údaje

Originální název

T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency

Název česky

T- a B- lymfocytární subpopulace a aktivační/diferenciační znaky u nemocných se selektivní deficitem IgA

Autoři

LITZMAN, Jiří; Marcela VLKOVÁ; Zdenka PIKULOVÁ; Dagmar ŠTIKAROVSKÁ a Jindřich LOKAJ

Vydání

Clin Exp Immunol, 2007, 0009-9104

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.599

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/07:00019151

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

common variable immunodefciency; IgA deficiency; lymphocyte subpopulations

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 4. 2010 08:05, prof. MUDr. Jiří Litzman, CSc.

Anotace

V originále

Selective deficiency of immunoglobulin A (IgAD) and common variable immunodeficiency (CVID) are genetically closely related diseases, both of unknown pathogenesis. A plethora of abnormalities in lymphocyte subpopulations and expression of activation markers were repeatedly documented in CVID patients, while almost no data are available about lymphocyte subpopulations in IgAD patients. We determined basic lymphocyte subpopulations and those subpopulations that were reported to be abnormal in CVID patients (CD25, human leucocyte antigen (HLA)-DR CD45RA, CD45RO, CD27, CD28 and CD29 on both CD4(+) and CD8(+) cells, CD57 and CD38 on CD8(+) cells, CD21, CD27, IgM, IgD on B lymphocytes) in 85 patients with IgAD, 47 patients with CVID and in 65 healthy controls. Statistical analysis was performed by the Mann-Whitney U-test; significant P-values were determined by means of Bonferoni's correction. Our results showed an increase in the relative number of CD8(+) cells and a decrease in the absolute number of CD4(+) cells compared to healthy people, but similar abnormalities in CVID patients were much more expressed. IgAD patients had significantly decreased expression of HLA-DR and increased expression of CD25 on CD4(+) lymphocytes, also CD29 expression was decreased on CD8(+) cells, while other activation/differentiation markers on T cells (including the expression of CD45RA and CD45RO antigens) were not changed. There were no statistically significant abnormalities in B lymphocyte developmental stages in IgAD patients compared to healthy controls. Our observation showed that the majority of T and B lymphocyte subpopulation abnormalities described previously in CVID are not present in IgAD patients.

Česky

Byly měřeny aktivační a diferenciační znaky T-a B-lymfocytů u nemocných s IgAD a byla srovnány s nemocnými s CVID a s normálními osobami.

Návaznosti

NR7981, projekt VaV
Název: Lymfocytární subpopulace u pacientů s humorálními imunodeficity
Investor: Ministerstvo zdravotnictví ČR, Lymfocytární subpopulace u pacientů s humorálními imunodeficity